News

Dr. Rhonda K. Yantiss Appointed to the Test Development and Advisory Committee for Gastrointestinal, Liver, and Pancreatic Pathology

January 9, 2020

Rhonda Yantiss, MD
Professor of Pathology and Laboratory Medicine

The American Board of Pathology (ABPath) is pleased to announce the appointment of Rhonda K. Yantiss to the ABPath’s Test Development and Advisory Committee (TDAC) for Gastrointestinal, Liver, and Pancreatic pathology for 2020. The TDACs are responsible for developing and reviewing the ABPath certification exam questions that assess and certify a physician’s education, knowledge, experience, and skills in order to provide high quality care in the pathology profession.

To be appointed to a TDAC means a physician is an established subject matter expert in their subspecialty field and is current on the latest advances in the continually evolving field of pathology and patient care. TDAC committee members develop and review examination questions for statistical performance and relevance to current practice. They contribute to the validity of examinations by determining the content and distribution of items on examinations (exam blueprints). The TDACs also advise the ABPath on issues in their subspecialty area of expertise.

“As TDAC members, these physicians play a critical role in the development of the exams and are entrusted with maintaining the integrity of the board-certified designation. The appointment to a TDAC indicates the physician is highly regarded in the field of pathology and exemplifies the utmost standards of care,” states Rebecca L. Johnson, M.D., CEO of the American Board of Pathology.

Dr. Alain Borczuk and Colleagues Receive Prestigious Cancer Moonshot Grant

November 25, 2019

borczuk_alain_web.jpg

Dr. Alain Borczuk
Professor of Pathology and Laboratory Medicine

Cancer Moonshot Grant Funds Research into Discovering Targets for Lung Cancer Prevention Strategies

Weill Cornell Medicine has received a prestigious Cancer Moonshot grant from the National Cancer Institute’s Immuno-Oncology Translational Network (IOTN) to explore the mechanisms that allow slow-growing lung cancer lesions to progress into aggressive malignancies and identify new therapeutic strategies to intercept the transition.

The competitive grant was one of only three awarded this year. The Weill Cornell Medicine investigators, led by Dr. Nasser Altorki, director of the Neuberger Berman Lung Cancer Research Center and the David. B. Skinner Professor of Thoracic Surgery, will receive up to $4.2 million in funding over five years to pursue their research.

The Cancer Moonshot initiative supports scientific research with the potential to accelerate the understanding of cancer and identify new ways to intercept its initiation and progression. Congress established the program in 2016 as part of the 21st Century Cures Act, with a total of $1.8 billion administered over seven years by the National Cancer Institute.

“Our previous work suggests that the progression from precancerous to aggressive lung cancer is associated with the development of a significantly suppressed immune response in the tumor microenvironment,” said Dr. Altorki, who also leads the Experimental Therapeutics Program of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and is a thoracic surgeon at NewYork-Presbyterian/Weill Cornell Medical Center. “With this grant, we will generate crucial insights into the complex interactions that take place between cancer cells and the surrounding cells, including the immune cells they must suppress to survive. We anticipate those insights will reveal a major breakthrough that could be tested in future clinical trials.”

The Pathologist Names Dr. Genevieve Crane "Trailblazer of the Lab"

September 10, 2019

crane-genevieve_web.jpg

Genevieve Crane, MD, PhD
Assistant Professor of Pathology

The Pathologist has named Genevieve Crane, MD, PhD a "Trailblazer of the Lab" in their 2019 Power List.

“'Pathology provides a truly unique opportunity to build a niche based on your passion and skillsets, directly impacting the field and potentially the lives of others,' says Eve, Assistant Professor of Pathology at Weill Cornell Medicine in New York City. Alongside her research interest in investigating the influence of host and environmental factors on lymphoma development, she is also passionate about education and outreach, especially through social media. With over 5,000 followers on Twitter, she frequently uses her powerful online presence to prompt and engage in discussions surrounding her specialty – diagnostic hematopathology."

Read the full article on The Pathologist.

You are here